Skip to content

Hyloris: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Hyloris

BE 0669.738.676
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€100,517
2024 · €22,759-€123,276
Equity
€706,225
2024 · -€1.7m+€2.4m
Cash
€298,658
2024 · €580,519-€281,861
Balance sheet total
€1.6m
2024 · €996,554+€581,835

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€776,068

    up €776,068 (+3917.2%), from €19,812 to €795,880

    of which Trade receivables: +€764,855

  • Cash -€281,861

    down €281,861 (-48.6%), from €580,519 to €298,658

    mainly Other debts (-€2.0m) and Receivables within one year (-€776,068)

  • Stocks and contracts +€51,748

    new in 2025: €51,748

  • Intangible fixed assets +€48,225

    up €48,225 (+13.7%), from €353,175 to €401,400

Equity and liabilities
  • Other debts -€2.0m

    down €2.0m (-75.8%), from €2.6m to €627,956

  • Profit (loss) carried forward +€1.7m

    up €1.7m (+94.3%), from -€1.8m to -€100,517

  • Contributions +€744,742

    up €744,742 (+1201.2%), from €62,000 to €806,742

  • Trade debts +€144,156

    up €144,156 (+144.1%), from €100,052 to €244,208

Income statement
  • Purchases and services +€870,009

    new in 2025: €870,009

  • Turnover +€384,852

    new in 2025: €384,852

  • Gross operating margin -€134,102

    down €134,102 (-78.6%), from €170,697 to €36,595

  • Provisions -€36,343

    new in 2025: -€36,343

  • Depreciation +€23,506

    up €23,506 (+1544.4%), from €1,522 to €25,028

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €22,759
Gross operating margin -€134,102
Depreciation -€23,506
Provisions +€36,343
Other operating charges -€2,734
Financial income +€1,034
Financial charges +€12,439
Taxes -€12,750
Result 2025 -€100,517

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€2.7m
Investment -€73,253
Financing +€2.5m
Cash 2024 €580,519
Net result for the year -€100,517
Depreciation +€25,028
Receivables after one year +€12,345
Stocks and contracts -€51,748
Receivables within one year -€776,068
Trade debts +€144,156
Other debts -€2.0m
Investment in fixed assets (net) -€73,253
Contributions, distributions and other +€2.5m
Cash 2025 €298,658
Every line side by side 38 lines
Line Code 2024 2025 Change %
Total assets 20/58 €996,554 €1,578,389 +€581,835 +58.4%
Fixed assets 21/28 €353,175 €401,400 +€48,225 +13.7%
Intangible fixed assets 21 €353,175 €401,400 +€48,225 +13.7%
Current assets 29/58 €643,379 €1,176,989 +€533,610 +82.9%
Amounts receivable after more than one year 29 €43,048 €30,703 -€12,345 -28.7%
Other amounts receivable 291 €43,048 €30,703 -€12,345 -28.7%
Stocks and contracts in progress 3 - €51,748 +€51,748
Stocks 30/36 - €51,748 +€51,748
Amounts receivable within one year 40/41 €19,812 €795,880 +€776,068 +3917.2%
Trade receivables 40 - €764,855 +€764,855
Other amounts receivable 41 €19,812 €31,025 +€11,213 +56.6%
Cash at bank and in hand 54/58 €580,519 €298,658 -€281,861 -48.6%
Total equity and liabilities 10/49 €996,554 €1,578,389 +€581,835 +58.4%
Equity 10/15 -€1,693,258 €706,225 +€2.4m
Contributions 10/11 €62,000 €806,742 +€744,742 +1201.2%
Capital 10 €62,000 €806,742 +€744,742 +1201.2%
Issued capital 100 €62,000 €806,742 +€744,742 +1201.2%
Profit (loss) carried forward 14 -€1,755,258 -€100,517 +€1.7m +94.3%
Amounts payable 17/49 €2,689,812 €872,164 -€1.8m -67.6%
Amounts payable within one year 42/48 €2,689,812 €872,164 -€1.8m -67.6%
Trade debts 44 €100,052 €244,208 +€144,156 +144.1%
Suppliers 440/4 €100,052 €244,208 +€144,156 +144.1%
Other amounts payable 47/48 €2,589,760 €627,956 -€2.0m -75.8%
Turnover 70 - €384,852 +€384,852
Goods, raw materials, services and sundry goods 60/61 - €870,009 +€870,009
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,522 €25,028 +€23,506 +1544.4%
Provisions for liabilities and charges: additions (uses and reversals) 635/8 - -€36,343 -€36,343
Other operating charges 640/8 €607 €3,341 +€2,734 +450.4%
Gross operating margin 9900 €170,697 €36,595 -€134,102 -78.6%
Operating profit (loss) 9901 €168,568 €44,569 -€123,999 -73.6%
Financial income 75/76B €18,896 €19,930 +€1,034 +5.5%
Recurring financial income 75 €18,896 €19,930 +€1,034 +5.5%
Financial charges 65/66B €174,022 €161,583 -€12,439 -7.1%
Recurring financial charges 65 €174,022 €161,583 -€12,439 -7.1%
Profit (loss) for the period before taxes 9903 €13,442 -€97,084 -€110,526
Income taxes 67/77 -€9,317 €3,433 +€12,750
Profit (loss) for the period 9904 €22,759 -€100,517 -€123,276
Profit (loss) for the period to be appropriated 9905 €22,759 -€100,517 -€123,276

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.